Addiction News

TORONTO — Preliminary results of a project to educate practitioners about naloxone use showed it improved their knowledge of the opioid antagonist and significantly increased naloxone distribution to patients at a Los Angeles clinic.

The FDA has approved an abbreviated new drug application for naloxone hydrochloride nasal spray, paving the way for the opioid overdose treatment to be available without a prescription.

BOSTON — In this video, an expert reviews current topics in addiction medicine, like ties between cannabis use and cardiovascular health, buprenorphine access and pre-operative alcohol assessments.

BOSTON — There is some evidence that cannabinoids may help with neuropathic pain, chemotherapy-induced nausea/vomiting and MS-associated spasticity, “but it’s not exactly a slam dunk,” a speaker said.

Adults with strabismus were more likely to have mental health conditions, including anxiety, depression and substance use and addiction, compared with those without strabismus, according to a study published in JAMA Ophthalmology.

DENVER — Researchers have recruited women with multiple sclerosis for a study using a home-based telehealth intervention for cannabis use disorder, according to a poster presented at the American Academy of Neurology annual meeting.

Two pediatric addiction medical specialists and a mother who lost her daughter to fentanyl poisoning collaborated to write anticipatory guidance that may help pediatricians counsel patients and families on overdose prevention strategies.

The elevated propensity for peripheral artery disease in patients with major depression may be mediated by increased liability for lifetime smoking and BMI, according to research in the Journal of the American Heart Association.

The Substance Abuse and Mental Health Services Administration issued a final rule that permanently allows patients to be prescribed buprenorphine via telehealth, the U.S. Department of Health and Human Services announced in a press release.

Residential addiction treatment centers serving adolescents are scarce and expensive in the United States, new study findings suggest, despite increasing overdose rates among young people in recent years.